AstraZeneca Eliminates Around 600 US Positions in Cost-Cutting Program
AstraZeneca has eliminated around 600 positions in the US as part of a cost-cutting program.
AstraZeneca has eliminated around 600 positions in the US as part of a cost-cutting program.